Abiopharma

New Form SC 13E3/A - Perfect Corp. <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001104659-26-101025 <b>Size:</b> 2 MB

Quarterly Report as at 30 June 2026

The company’s liability position as of 30.6.26, by maturity dates

Quarter 2 / Semi-Annual report for 2026

New Form 3 - Linkers Industries Ltd <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001213900-26-093709 <b>Size:</b> 3 KB

The company’s liability position as of June 30, 2026, by maturity dates

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001213900-26-093703 <b>Size:</b> 241 KB

Q2/half-year report for 2026

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001213900-26-093699 <b>Size:</b> 2 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024809 <b>Size:</b> 439 KB

New Form EFFECT - Check-Cap Ltd <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 9999999995-26-002756 <b>Size:</b> 1 KB

New Form EFFECT - Indaptus Therapeutics, Inc. <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 9999999995-26-002761 <b>Size:</b> 1 KB

New Form EFFECT - 60 DEGREES PHARMACEUTICALS, INC. <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 9999999995-26-002759 <b>Size:</b> 1 KB

New Form EFFECT - BCB BANCORP INC <b>Filed:</b> 2026-08-25 <b>AccNo:</b> 9999999995-26-002758 <b>Size:</b> 1 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024808 <b>Size:</b> 431 KB